recruitment of subjects

recruitment of subjects

The process used by clinical trial investigators to find and enrol appropriate subjects/patients based on a protocol's inclusion and exclusion criteria into the study.
References in periodicals archive ?
The recruitment of subjects (AOK insured, third-party insured) is carried out by the Contractor.
The commencement of the trial is subject to receipt of Investigational Review Board approvals (the equivalent of Helsinki Committee approvals) from the participating sites, and to the recruitment of subjects.
Based on the information through CTRI, there have been certain instances where there has been a bias in allocation of recruitment of subjects for the Indian arm in global clinical trials.
Generally, they are designed for rapid recruitment of subjects and are approved only after data from Phase II trials indicate that the drug is effective for the condition under study.
Setting: Recruitment of subjects from: the Heidelberg Prospective Intervention Study, six hospital and after-care institutions in Germany, and the Institute for Preventive Medicine in Heidelberg.
Strategies for assessment and recruitment of subjects for nursing research.
The Cardiovascular Risk in Young Finns Study began in 1980 with random recruitment of subjects 3-18 years of age from the Finnish national register and included follow-up studies in 1983 and 1986.
Such an approach might entail the recruitment of subjects for two ostensibly unrelated tasks--to provide feedback about a pilot television show that is under consideration for syndication and to provide information about how they plan their meals.
lt is obvious that recruitment of subjects for experimental studies is a difficult problem.
Bartlett makes lucid and apposite use of what she draws from them, however, and her discussion of the textual recruitment of subjects seems worth extending.
AD biomarkers offer utility in a number of ways: identification of groups at risk of developing AD; early detection of AD; differentiation of different forms of neurodegenerative disease from AD, as well as developmental stages (such as MCI), thought to progress to AD; supporting specific treatments or pharmacological interventions; following the time-course progression of AD and response to therapy; assessing patient prognosis; advancing understanding of the disease, including risk factors, and the changes that precede its development; the identification of new drug targets and candidate molecules; development of discovery assays for efficacy or toxicity markers; and supporting the recruitment of subjects most likely to provide a meaningful analysis of treatment effects.
CrowdGather will initially pursue the recruitment of subjects to beta test and validate the latest version of Network Signatures EasyConnect platform.
Full browser ?